Log In
Print this Print this

NeuVax, nelipepimut-S (E75)

  Manage Alerts
Collapse Summary General Information
Company Galena Biopharma Inc.
DescriptionVaccine consisting of an immunogenic peptide derived from epidermal growth factor receptor 2 (EGFR2; HER2; ErbB2; neu) and sargramostim
Molecular Target
Mechanism of ActionVaccine; Immunotherapy
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today